Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-04-000157
Filing Date
2004-02-13
Accepted
2004-02-13 13:37:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 bvf-zonagen_13ga.htm SC 13G/A 107365
3 ex-1.htm EX-99 7379
  Complete submission text file 0000898432-04-000157.txt   116921
Mailing Address 2408 TIMBERLOCH PLACE B-4 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-4 WOODLANDS TX 77380 2813675892
ZONAGEN INC (Subject) CIK: 0000897075 (see all company filings)

EIN.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52909 | Film No.: 04597010
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice